C85.82 Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes

Name of the Condition

• Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes
• C85.82

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers affecting the lymphatic system. This code represents NHL types that do not fit into more specific subcategories and are explicitly documented as "other specified" in clinical records, with involvement of intrathoracic lymph nodes (e.g., mediastinal, hilar, or other thoracic nodal regions). The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Persistent cough or chest discomfort
• Shortness of breath
• Chest pain or pressure

Diagnosis

Diagnosis typically involves a physical exam to check for swollen lymph nodes, blood tests to assess blood cell levels, imaging tests like CT or PET scans to evaluate intrathoracic involvement, and potentially a biopsy to examine lymphatic tissue. Additional tests may include bone marrow aspiration or lumbar puncture if central nervous system involvement is suspected.

Treatment Options

Treatment depends on the specific type and progression of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or stem cell transplantation. The choice of treatment is guided by factors such as the lymphoma subtype, stage, patient age, and overall health.

Prognosis and Follow-Up

Prognosis varies based on the lymphoma subtype, stage, and patient response to treatment. Regular follow-up appointments are essential to monitor for recurrence or treatment-related complications. Long-term surveillance may include imaging studies, blood tests, and clinical assessments.

Complications

• Recurrence of lymphoma
• Infection due to weakened immune system
• Treatment-related side effects (e.g., fatigue, nausea, organ damage)
• Transformation to a more aggressive lymphoma subtype
• Respiratory complications from intrathoracic involvement

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid exposure to known carcinogens (e.g., pesticides, herbicides).
• Practice safe behaviors to reduce infection risk (e.g., safe sex, hand hygiene).
• Stay up-to-date with vaccinations, as recommended by a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention for symptoms such as severe chest pain, difficulty breathing, unexplained weight loss, or persistent fever. Regular follow-up with a hematologist or oncologist is recommended for ongoing management of the condition.

Tips for Medical Coders

This code (C85.82) is used for other specified types of non-Hodgkin lymphoma with documented involvement of intrathoracic lymph nodes. Clinical documentation must specify both the "other specified" lymphoma type and the intrathoracic nodal location to support accurate coding. Ensure the diagnosis aligns with the ICD-10-CM guidelines for lymphoma coding, and verify that more specific codes are not applicable before using this code.